Mapmygenome has completed its acquisition of Vancouver-based dnaPower, expanding its North American operations and adding capabilities across DNA testing, microbiome health, longevity, ...

For rural Mainers with cancer, advanced care once meant driving to Boston or traveling to an academic center. A decade in, the Jackson Laboratory’s Maine Cancer Genomics Initiative says it has flipped ...

A Global Initiative by Abu Dhabi has released a new white paper in collaboration with Knowledge Contributor Strategy creating ...

Researchers from Newcastle University and Great Ormond Street Hospital have identified new predictors of relapse in children and young people with acute lymphoblastic leukemia (ALL) treated with the ...

HIV may be suppressed by antiretroviral therapy, but its genetic material remains in the body. New research by scientists at ...

Cleveland Clinic Abu Dhabi and AstraZeneca launch a new collaboration positioning Abu Dhabi as a priority location in AstraZeneca’s global clinical trial network The collaboration leverages the ...

Mapmygenome, a personal genomics and precision medicine player from Hyderabad, has acquired Vancouver-based personal genomics ...

Illumina, Inc. (NASDAQ: ILMN) today introduced three early-access capabilities on its BioInsight Platform that help ...

Hyderabad genomics firm Mapmygenome has acquired Vancouver-based dnaPower to scale its precision health and longevity testing ...

Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Mexico Genomics Market Size, Share, Trends and Forecast by Component, Application, Technology, End-User, and Region, 2026-2034" has been added to ...

Genomics advances, digital health adoption and personalized care drive opportunities across oncology, diagnostics and rare disease management in Mexico.Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- ...

Mapmygenome completes dnaPower acquisition, creating a central North American platform for DNA, microbiome, pharmacogenetics, ...